The Journal of Rheumatology · 2016 · 31 citations · 22 references
MedicineOrthopaedic SurgeryOrthopedic SurgeryAgingCartilage RepairRheumatologyCartilage BiologyCartilage BreakdownCartilage DegenerationJoint DegenerationJoint DiseaseOsteoarthritisArticular Cartilage LossBiomarkers Of Cartilage BreakdownBiomarkers Of Cartilage DamageBiomarkers Of Joint DegenerationCartilage Degradation MechanismsCartilage DestructionKnee RadiographyType Ii Collagen Degradation
OBJECTIVE: To evaluate the association of a sandwich assay for cartilage collagenase-mediated degradation, the C2C human urine sandwich assay (IB-C2C-HUSA), with early and late knee cartilage pathology and with progression of cartilage damage. METHODS: A population-based cohort with knee pain, age 40-79 years, was evaluated at baseline (n = 253) and after mean 3.3 years (n = 161). We evaluated the IB-C2C-HUSA and a related competitive inhibition assay (C2C). The C2C assay was applied to serum (sC2C) and urine (uC2C). Based on knee radiographs and magnetic resonance imaging (MRI), 3 subgroups [no cartilage pathology, preradiographic cartilage pathology, and radiographic osteoarthritis (ROA)] were evaluated cross-sectionally for association with biomarker levels. Longitudinally, we evaluated whether baseline assays predict subsequent progression of cartilage degeneration, defined by MRI cartilage loss. RESULTS: Cross-sectionally, statistically significant differences were seen in the 3 subgroups for IB-C2C-HUSA (p < 0.001), with the highest levels seen in ROA, and for sC2C (p = 0.023), while no differences were seen for uC2C (p = 0.501). Baseline IB-C2C-HUSA levels were higher in progressors vs nonprogressors (p = 0.003). In logistic regression analysis, only baseline IB-C2C-HUSA was associated with an increased risk of progression of cartilage damage (OR 1.78, 95% CI 1.03-3.09). CONCLUSION: The IB-C2C-HUSA degradation assay detects the generation of a pathology-related cartilage collagen peptide(s) that increase(s) with onset of degeneration of knee articular cartilage. The baseline values are associated with progression of cartilage degeneration over 3 subsequent years. This assay may have value in clinical OA trials. Further, it points to collagenase activity as a therapeutic target for controlling degeneration of articular cartilage.
22
Radiological Assessment of Osteo-Arthrosis
Jan Kellgren, J. S. Lawrence · Annals of the Rheumatic Diseases · 1957 · 12.4K citations · Full text
Nicholas Bellamy, W. Watson Buchanan, Charles H. Goldsmith et al. · PubMed · 1988 · 7.8K citations